Camptothecin계 항암제 CKD-602의 유전독성평가 ( Genotoxicity Studies of An Anticancer Agent of Camptothecin Series, CKD-602 )

하광원 ,  오혜영 ,  허옥순 외 9명

한국환경성돌연변이·발암원학회지

1998 .09

신규 캄토테신계 항암제 CKD-602의 약물동태: 분포, 대사 및 배설

이주몽 ,  이준희 ,  김준겸 외 4명

약학회지

1998 .01

구강암 세포주에 대한 CKD-602의 항암 효과

윤필영 ,  옥용주 ,  명훈 외 2명

대한구강악안면외과학회지

2005 .01

Development of Liposomal Formulations of a Camptothecin Derivative

Shim ,  J.Y. ,  Kim 외 1명

대한약학회 학술대회

2001 .01

신규 캄토테신계 항암제 CKD-602의 약물동태: 흡수

이주몽 ,  손용성 ,  김준겸 외 4명

약학회지

1998 .01

In Vitro Pharmacodynamics of CKD-602 in HT-29 Cells

Pa ,  k ,  In-Sook 외 15명

Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea

2002 .01

Comparison of Single-Dose Toxicity by Intravenous Infusion or Bolus Injection with CKD-602, a Camptothecin Anticancer Agent in Rats (II): Hematological and Serum Biochemical, and Histopathological Changes

Choong-Yong Kim ,  Byung-Chul Yang ,  Joon-Kyum Kim 외 4명

Toxicological Research

2004 .12

Characterization and Growth Inhibitory Effect of the PEGylated Liposome-incorporated Camptothecin derivative

Shim ,  J.Y. ,  Kim 외 1명

대한약학회 학술대회

2000 .01

Antitumor Activity of 7-[2-(N-Isopropylamino)ethyl]-(20s)-camptothecin, CKD602, as a Potent DNA Topoisomerase I Inhibitor

Lee ,  Jun-Hee ,  Lee 외 16명

Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea

1998 .01

Association of Demographic and Socioeconomic Factors With Risk Factors for Chronic Kidney Disease

Jae-Woo Choi ,  김태현 ,  Min-Jee Lee 외 2명

예방의학회지

2015 .01

Absorption, Distribution, Metabolism, and Excretion of CKD-732, a Novel Antiangiogenic Fumagillin Derivative, in Rats, Mice, and Dogs

Lee ,  Ho-Sup ,  Pa 외 18명

Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea

2004 .01

Toxicity Study of CKD-602, a Camptothecin Anticancer Agent: 5-Day Repeated Intravenous Administration in Rats

Han ,  Jung-Hee ,  Cha 외 13명

The journal of applied pharmacology : the official journal of the Korean Society of Applied Pharmacology

2004 .01

Identification of urinary metabolite(s) of CKD-712 by gas chromatography/mass spectrometry in rats

Jean ,  Hee-Kyung ,  Choi 외 7명

대한약학회 학술대회

2003 .01

Higher Risk for All-cause Mortality of Staphylococcus aureus Bacteremia in Patients with Non-Dialysis Dependent Chronic Kidney Disease

김연숙

Infection and Chemotherapy

2020 .01

Comparison of Single-Dose Toxicity by Intravenous Infusion or Bolus Injection with CKD-602, a Camptothecin Anticancer Agent in Rats (I): Toxic Effects with regard to Mortality and Clinical Signs

Choong-Yong Kim ,  Junghee Han ,  Byung-Chul Yang 외 4명

Toxicological Research

2004 .12

Acute Toxicity of CKD-602, a New Anticancer Agent, in Rats

Kim ,  Jong-Choon ,  Shin 외 13명

The journal of applied pharmacology : the official journal of the Korean Society of Applied Pharmacology

2004 .01

CKD-712, (S)-1-(α-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, Inhibits the NF-κB Activation and Augments Akt Activation during TLR4 Signaling

Lee ,  Jeong-Gi ,  Yang 외 9명

Immune Network

2011 .12

Effect of chronic kidney disease on outcomes of total joint arthroplasty: a meta-analysis

Chang-Wan Kim ,  Hyun Jung Kim ,  Chang-Rack Lee 외 2명

Knee Surgery and Related Research

2020 .01

Phase I Study of CKD-516, a Novel Vascular Disrupting Agent, in Patients with Advanced Solid Tumors

오도연 ,  김태민 ,  한세원 외 8명

Cancer Research and Treatment

2016 .01